27-HC, which is synthesized with CYP27A1 and released in an autocrine manner by myeloid cells, works on myeloid cells through LXR-ABCA1 to suppress cytotoxic CD8+ T cell activity, eventually promoting breast cancer progression. Here, CYP27A1 is linked to breast cancer.